Your session is about to expire
← Back to Search
PDL + Fractional Photothermolysis for Scarring
N/A
Waitlist Available
Led By Murad Alam, MD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months
Awards & highlights
Study Summary
This trial is evaluating the efficacy of early combined PDL (pulsed dye laser) and fractional photothermolysis in the cosmetic improvement of post surgical scars. Subjects will have the choice of whether or not they will receive treatment in part A, and subjects will be randomized in a 2:1 treatment vs. control design in part B.
Who is the study for?
This trial is for adults over 18 in good health who have had dermatologic surgery on their trunk or limbs and are healing with a specific type of suture. They must not be pregnant, breastfeeding, prone to severe scarring, or have certain skin infections. Participants should live near Chicago and stop using topical retinoids one week before treatment.Check my eligibility
What is being tested?
The study tests the effectiveness of combining two laser treatments (PDL and fractional photothermolysis) on improving the appearance of post-surgical scars. Part A lets subjects choose to receive treatment; Part B randomly assigns them to either get treated or serve as controls in a 2:1 ratio.See study design
What are the potential side effects?
Potential side effects from the laser treatments may include redness, swelling, bruising at the treated area, changes in skin pigmentation, discomfort during the procedure, and rare chances of scarring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in score of Patient and Observer Scar Assessment Scale (POSAS)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: PDL (Pulsed Dye Laser) and Fractional PhotothermolysisExperimental Treatment2 Interventions
Group II: ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,081 Total Patients Enrolled
Murad Alam, MDPrincipal InvestigatorNorthwestern University
69 Previous Clinical Trials
2,430 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I understand the study and can give my consent.I had skin surgery on my body or limbs with stitches that were removed in 2-3 weeks.I will stop using topical retinoids one week before treatment.I can understand and agree to participate in the study.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: PDL (Pulsed Dye Laser) and Fractional Photothermolysis
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger